Juratli TA - Search Results

1

Is there pseudoprogression in secondary glioblastomas?

Juratli TA, Engellandt K, Lautenschlaeger T, Geiger KD, von Kummer R, Cerhova J, Chakravarti A, Krex D, Schackert G. Juratli TA, et al. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1094-9. doi: 10.1016/j.ijrobp.2013.09.036. Int J Radiat Oncol Biol Phys. 2013. PMID: 24267971 Free PMC article.

2

The prostate stem cell antigen represents a novel glioma-associated antigen.

Geiger KD, Hendruschk S, Rieber EP, Morgenroth A, Weigle B, Juratli T, Senner V, Schackert G, Temme A. Geiger KD, et al. Oncol Rep. 2011 Jul;26(1):13-21. doi: 10.3892/or.2011.1265. Epub 2011 Apr 15. Oncol Rep. 2011. PMID: 21503583

3

IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas.

Juratli TA, Kirsch M, Robel K, Soucek S, Geiger K, von Kummer R, Schackert G, Krex D. Juratli TA, et al. J Neurooncol. 2012 Jul;108(3):403-10. doi: 10.1007/s11060-012-0844-1. Epub 2012 Mar 13. J Neurooncol. 2012. PMID: 22410704

4

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.

Juratli TA, Kirsch M, Geiger K, Klink B, Leipnitz E, Pinzer T, Soucek S, Schrock E, Schackert G, Krex D. Juratli TA, et al. J Neurooncol. 2012 Dec;110(3):325-33. doi: 10.1007/s11060-012-0977-2. Epub 2012 Sep 27. J Neurooncol. 2012. PMID: 23015095

5

[Rupture of an intracranial mature teratoma].

Daubner D, Juratli TA, Engellandt K. Daubner D, et al. Among authors: juratli ta. Rofo. 2013 Jan;185(1):71-3. doi: 10.1055/s-0032-1313212. Epub 2012 Sep 21. Rofo. 2013. PMID: 23023226 German. No abstract available.

6

A newly developed drill with a polished tip for the anterior cervical approach in spinal canal stenosis: a technical note.

Leimert M, Bostelmann R, Juratli TA, Mikulin HD, Herrmann B, Schackert G, Reitemeier B. Leimert M, et al. Among authors: juratli ta. Eur Spine J. 2013 Apr;22(4):809-12. doi: 10.1007/s00586-012-2572-9. Epub 2012 Nov 22. Eur Spine J. 2013. PMID: 23179976 Free PMC article.

7

Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas.

Juratli TA, Peitzsch M, Geiger K, Schackert G, Eisenhofer G, Krex D. Juratli TA, et al. Neuro Oncol. 2013 Jun;15(6):682-90. doi: 10.1093/neuonc/not006. Epub 2013 Feb 14. Neuro Oncol. 2013. PMID: 23410661 Free PMC article.

8

Anticoagulation management of myocardial infarction after deep brain stimulation: a comparison of two cases.

Polanski W, Koy J, Juratli T, Wolz M, Klingelhöfer L, Fauser M, Storch A, Schackert G, Sobottka SB. Polanski W, et al. Acta Neurochir (Wien). 2013 Sep;155(9):1661-5; discussion 1664-5. doi: 10.1007/s00701-013-1679-z. Epub 2013 Apr 7. Acta Neurochir (Wien). 2013. PMID: 23563744

9

Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

Juratli TA, Schackert G, Krex D. Juratli TA, et al. Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Pharmacol Ther. 2013. PMID: 23694764 Review.

10

[Differential Diagnosis of Intrasellar and Suprasellar Neoplasia ].

Daubner D, Juratli TA, Engellandt K, von Kummer R, Hahn G, Schackert G, Pinzer T. Daubner D, et al. Among authors: juratli ta. Rofo. 2013 Jun;185(6):515-20. doi: 10.1055/s-0032-1319443. Epub 2013 Jun 5. Rofo. 2013. PMID: 23740700 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters